SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Melissa Colbert, Joanne Borg-Stein, Pathology and Intervention in Musculoskeletal Rehabilitation, 2016,

    CrossRef

  2. 2
    Alan G. Finkel, Botulinum toxin and the treatment of headache: A clinical review, Toxicon, 2015, 107, 114

    CrossRef

  3. 3
    Edward Nahabet, Jeffrey E. Janis, Bahman Guyuron, Neurotoxins, Plastic and Reconstructive Surgery, 2015, 136, 104S

    CrossRef

  4. 4
    Richard B. Lipton, Risk Factors for and Management of Medication-Overuse Headache, CONTINUUM: Lifelong Learning in Neurology, 2015, 21, 1118

    CrossRef

  5. 5
    Scott M. Whitcup, Catherine C. Turkel, Ronald E. DeGryse, Mitchell F. Brin, Development of onabotulinumtoxinA for chronic migraine, Annals of the New York Academy of Sciences, 2014, 1329, 1
  6. 6
    Stephen D. Silberstein, Richard B. Lipton, David W. Dodick, Operational Diagnostic Criteria for Chronic Migraine: Expert Opinion, Headache: The Journal of Head and Face Pain, 2014, 54, 7
  7. 7
    Ivica Matak, Ivana Stracenski, Zdravko Lacković, Comparison of analgesic effects of single versus repeated injection of botulinum toxin in orofacial formalin test in rats, Journal of Neural Transmission, 2013, 120, 1, 141

    CrossRef

  8. 8
    Daghan Isik, Hakan Tekin, Remzi Karadag, Serap Gunes Bilgili, Bekir Atik, Effect of Brow Lifting Using Botulinum A Toxin on Upper Eyelid Height in Patients With Ptosis Undergoing the Frontal Sling Technique, Annals of Plastic Surgery, 2013, 70, 2, 175

    CrossRef

  9. 9
    Patrick M. Grogan, Maria Victoria Alvarez, Lyell Jones, Headache Direction and Aura Predict Migraine Responsiveness to Rimabotulinumtoxin B, Headache: The Journal of Head and Face Pain, 2013, 53, 1
  10. 10
    Avi Ashkenazi, Andrew Blumenfeld, OnabotulinumtoxinA for the Treatment of Headache, Headache: The Journal of Head and Face Pain, 2013, 53,
  11. 11
    Hans-Christoph Diener, David W. Dodick, Peter J. Goadsby, Richard B. Lipton, Jes Olesen, Stephen D. Silberstein, Chronic migraine—classification, characteristics and treatment, Nature Reviews Neurology, 2012, 8, 3, 162

    CrossRef

  12. 12
    Luana Lionetto, Andrea Negro, Stefano Palmisani, Giovanna Gentile, Maria Rosaria Del Fiore, Marco Mercieri, Maurizio Simmaco, Thomas Smith, Adnan Al-Kaisy, Roberto Arcioni, Paolo Martelletti, Emerging treatment for chronic migraine and refractory chronic migraine, Expert Opinion on Emerging Drugs, 2012, 17, 3, 393

    CrossRef

  13. 13
    Carrie O. Dougherty, Stephen D. Silberstein, OnabotulinumtoxinA in the treatment of migraine headache, Techniques in Regional Anesthesia and Pain Management, 2012, 16, 1, 41

    CrossRef

  14. 14
    Alan G. Finkel, Botulinum Toxin and the Treatment of Headache: A Clinical Review, Headache: The Journal of Head and Face Pain, 2011, 51, 10
  15. 15
    Jung-Mi Park, Seong-Uk Park, Woo-Sang Jung, Sang-Kwan Moon, Carthami-Semen acupuncture point injection for chronic daily headache: A pilot, randomised, double-blind, controlled trial, Complementary Therapies in Medicine, 2011, 19, S19

    CrossRef

  16. 16
    J. A. de Ru, P. P. A. Schellekens, P. J. F. M. Lohuis, Corrugator supercilii transection for headache emanating from the frontal region: a clinical evaluation of ten patients, Journal of Neural Transmission, 2011, 118, 11, 1571

    CrossRef

  17. 17
    A. Oterino, C. Ramón, J. Pascual, Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks, The Journal of Headache and Pain, 2011, 12, 2, 235

    CrossRef

  18. 18
    Theodore A. Kung, Bahman Guyuron, Paul S. Cederna, Migraine Surgery: A Plastic Surgery Solution for Refractory Migraine Headache, Plastic and Reconstructive Surgery, 2011, 127, 1, 181

    CrossRef

  19. 19
    Shih-Pin Chen, Jong-Ling Fuh, Shuu-Jiun Wang, OnabotulinumtoxinA: Preventive Treatment for Chronic Migraine, Current Pain and Headache Reports, 2011, 15, 1, 4

    CrossRef

  20. 20
    Ivano Farinelli, Ilaria Dionisi, Paolo Martelletti, Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse?, Internal and Emergency Medicine, 2011, 6, 1, 23

    CrossRef

  21. 21
    Bahman Jabbari, Duarte Machado, Treatment of Refractory Pain with Botulinum Toxins—An Evidence-Based Review, Pain Medicine, 2011, 12, 11
  22. 22
    Behnam Bohluli, Mohammad Hosein Kalantar Motamedi, Shahrokh C. Bagheri, Mohammad Bayat, Eshagh Lassemi, Fina Navi, Nima Moharamnejad, Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2011, 111, 1, 47

    CrossRef

  23. 23
    K. Roger Aoki, Botulinum Toxins in Clinical Aesthetic Practice, 2011,

    CrossRef

  24. 24
    Suzanne N. Christie, Rose Giammarco, Marek Gawel, Gordon Mackie, Jonathan Gladstone, Werner J. Becker, Botulinum Toxin Type A and Acute Drug Costs in Migraine with Triptan Overuse, The Canadian Journal of Neurological Sciences, 2010, 37, 05, 588

    CrossRef

  25. 25
    Avi Ashkenazi, Botulinum Toxin Type A for Chronic Migraine, Current Neurology and Neuroscience Reports, 2010, 10, 2, 140

    CrossRef

  26. 26
    Stephen D. Silberstein, Michael J. Marmura, James Shaw, Shengsheng Yu, Headache Prophylaxis With BoNTA: Patient Characteristics, Headache: The Journal of Head and Face Pain, 2010, 50, 1
  27. 27
    Frederick G Freitag, Importance of botulinum toxin for prevention of migraine, Expert Review of Neurotherapeutics, 2010, 10, 3, 339

    CrossRef

  28. You have free access to this content28
    Andrew Blumenfeld, Stephen D. Silberstein, David W. Dodick, Sheena K. Aurora, Catherine C. Turkel, William J. Binder, Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program, Headache: The Journal of Head and Face Pain, 2010, 50, 9
  29. 29
    Alan M. Rapoport, New acute treatments for headache, Neurological Sciences, 2010, 31, S1, 129

    CrossRef

  30. 30
    Roger K Cady, OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine, Expert Opinion on Biological Therapy, 2010, 10, 2, 289

    CrossRef

  31. You have free access to this content31
    David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse, Sheena K. Aurora, Stephen D. Silberstein, Richard B. Lipton, Hans-Christoph Diener, Mitchell F. Brin, OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program, Headache: The Journal of Head and Face Pain, 2010, 50, 6
  32. 32
    Margaret F. Moloney, Lisa A. Cranwell-Bruce, Pharmacological Management of Migraine Headaches, The Nurse Practitioner, 2010, 35, 9, 16

    CrossRef

  33. 33
    Andy Pickett, Re-Engineering Clostridial Neurotoxins for the Treatment of Chronic Pain, BioDrugs, 2010, 24, 3, 173

    CrossRef

  34. 34
    C. Gaul, D. Holle, P.S. Sandor, S. Evers, G. Broessner, A. Straube, H.-C. Diener, Stellenwert der „Migränechirurgie“, Der Nervenarzt, 2010, 81, 4, 463

    CrossRef

  35. 35
    Fabio Valguarnera, Paolo Tanganelli, The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline, Neurological Sciences, 2010, 31, S1, 175

    CrossRef

  36. 36
    Elena López García, Sonia Santos Lasaosa, Luis Javier López del Val, Toxina Botulínica, 2010,

    CrossRef

  37. 37
    Alexander Mauskop, Headache, 2010,

    CrossRef

  38. 38
    A. Rapoport, Antimigraine drugs: new frontiers, Neurological Sciences, 2009, 30, S1, 49

    CrossRef

  39. 39
    Michael W. Neumeister, Christopher B. Chambers, Margo S. Herron, Kelli Webb, Joel Wietfeldt, Jessica N. Gillespie, Rueben A. Bueno, Carisa M. Cooney, Botox Therapy for Ischemic Digits, Plastic and Reconstructive Surgery, 2009, 124, 1, 191

    CrossRef

  40. 40
    Valerie W. Chan, E. Jane McCabe, Daune L. MacGregor, Botox Treatment for Migraine and Chronic Daily Headache in Adolescents, Journal of Neuroscience Nursing, 2009, 41, 5, 235

    CrossRef

  41. 41
    J A de Ru, J Buwalda, Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache, The Journal of Laryngology & Otology, 2009, 123, 04, 412

    CrossRef

  42. 42
    Vinod Kumar Gupta, CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine, Expert Review of Neurotherapeutics, 2009, 9, 11, 1595

    CrossRef

  43. You have free access to this content43
    S. Evers, J. Áfra, A. Frese, P. J. Goadsby, M. Linde, A. May, P. S. Sándor, EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force, European Journal of Neurology, 2009, 16, 9
  44. 44
    Ivano Farinelli, Sergio De Filippis, Gabriella Coloprisco, Serena Missori, Paolo Martelletti, Future drugs for migraine, Internal and Emergency Medicine, 2009, 4, 5, 367

    CrossRef

  45. 45
    Jasvinder A. Singh, Maren L. Mahowald, Siamak Noorbaloochi, Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial, Translational Research, 2009, 153, 5, 205

    CrossRef

  46. 46
    Mark Obermann, Hans-Christoph Diener, Is botulinum toxin useful in treating headache? No, Current Treatment Options in Neurology, 2009, 11, 1, 24

    CrossRef

  47. 47
    Avi Ashkenazi, Stephen Silberstein, Is botulinum toxin useful in treating headache? Yes, Current Treatment Options in Neurology, 2009, 11, 1, 18

    CrossRef

  48. 48
    Marco Aguggia, Local therapies in migraine, Neurological Sciences, 2009, 30, S1, 67

    CrossRef

  49. 49
    Rami Burstein, David Dodick, Stephen Silberstein, Migraine prophylaxis with botulinum toxin A is associated with perception of headache, Toxicon, 2009, 54, 5, 624

    CrossRef

  50. 50
    Francesca Galletti, Letizia Maria Cupini, Ilenia Corbelli, Paolo Calabresi, Paola Sarchielli, Pathophysiological basis of migraine prophylaxis, Progress in Neurobiology, 2009, 89, 2, 176

    CrossRef

  51. 51
    &NA;, Preventative therapy plays an important role in managing chronic daily headache in paediatric patients, Drugs & Therapy Perspectives, 2009, 25, 1, 10

    CrossRef

  52. 52
    Stephen D. Silberstein, Preventive Migraine Treatment, Neurologic Clinics, 2009, 27, 2, 429

    CrossRef

  53. 53
    Aubrey Manack, Catherine Turkel, Stephen Silberstein, The Evolution of Chronic Migraine: Classification and Nomenclature, Headache: The Journal of Head and Face Pain, 2009, 49, 8
  54. 54
    Roger K. Cady, The Future of Migraine: Beyond Just Another Pill, Mayo Clinic Proceedings, 2009, 84, 5, 397

    CrossRef

  55. 55
    Roger K. Cady, The Future of Migraine: Beyond Just Another Pill, Mayo Clinic Proceedings, 2009, 84, 5, 397

    CrossRef

  56. 56
    Avi Ashkenazi, The role of botulinum neurotoxin in pain management—An ongoing controversy, Current Pain and Headache Reports, 2009, 13, 4, 249

    CrossRef

  57. 57
    Stephen D. Silberstein, Botulinum Toxin, 2009,

    CrossRef

  58. 58
    Frederick Taylor, Clinician’s Guide to Chronic Headache and Facial Pain, 2009,

    CrossRef

  59. 59
    Catalina Apostol, Salahadin Abdi, Tobias Moeller-Bertram, Howard S. Smith, Charles E. Argoff, Mark Wallace, Current Therapy in Pain, 2009,

    CrossRef

  60. 60
    H.-C. Diener, Z. Katsarava, V. Limmroth, Aktuelle Diagnostik und Therapie der Migräne, Der Schmerz, 2008, 22, S1, 51

    CrossRef

  61. 61
    S. Evers, Alternativen zu Betablockern in der Migräneprophylaxe, Der Nervenarzt, 2008, 79, 10, 1135

    CrossRef

  62. 62
    Bahman Jabbari, Botulinum neurotoxins in the treatment of refractory pain, Nature Clinical Practice Neurology, 2008, 4, 12, 676

    CrossRef

  63. 63
    Roberto Casale, Valeria Tugnoli, Botulinum Toxin for Pain, Drugs in R & D, 2008, 9, 1, 11

    CrossRef

  64. 64
    Andrew M. Blumenfeld, Jack D. Schim, Thomas J. Chippendale, Botulinum Toxin Type A and Divalproex Sodium for Prophylactic Treatment of Episodic or Chronic Migraine, Headache: The Journal of Head and Face Pain, 2008, 48, 2
  65. 65
    Roger Cady, Curtis Schreiber, Botulinum Toxin Type A as Migraine Preventive Treatment in Patients Previously Failing Oral Prophylactic Treatment Due To Compliance Issues, Headache: The Journal of Head and Face Pain, 2008, 48, 6
  66. 66
    Giuseppe Nappi, Armando Perrotta, Paolo Rossi, Giorgio Sandrini, Chronic daily headache, Expert Review of Neurotherapeutics, 2008, 8, 3, 361

    CrossRef

  67. 67
    Joel R. Saper, Chronic daily headache: Transformational migraine, chronic migraine, and related disorders, Current Neurology and Neuroscience Reports, 2008, 8, 2, 100

    CrossRef

  68. 68
    Andrew J Dowson, Shaun G Kilminster, Rebecca Salt, Clinical Profile of Botulinum Toxin A in Patients with Chronic Headaches and Cervical Dystonia, Drugs in R & D, 2008, 9, 3, 147

    CrossRef

  69. 69
    W. J. Schulte-Mattler, E. Leinisch, Evidence based medicine on the use of botulinum toxin for headache disorders, Journal of Neural Transmission, 2008, 115, 4, 647

    CrossRef

  70. 70
    K. R. Aoki, Future aspects of botulinum neurotoxins, Journal of Neural Transmission, 2008, 115, 4, 567

    CrossRef

  71. 71
    Kenneth J Mack, Jack Gladstein, Management of Chronic Daily Headache in??Children and Adolescents, Pediatric Drugs, 2008, 10, 1, 23

    CrossRef

  72. 72
    Julio Pascual, Purificación Cacabelos, More lessons for the treatment of chronic daily headache, The Journal of Headache and Pain, 2008, 9, 1, 3

    CrossRef

  73. 73
    A. Straube, M. Empl, A. Ceballos-Baumann, T. Tölle, U. Stefenelli, V. Pfaffenrath, Pericranial injection of botulinum toxin type A (Dysport®) for tension-type headache – A multicentre, double-blind, randomized, placebo-controlled study, European Journal of Neurology, 2008, 15, 3
  74. 74
    Ninan T. Mathew, Jayasree Kailasam, Lori Meadors, Predictors of Response to Botulinum Toxin Type A (BoNTA) in Chronic Daily Headache, Headache: The Journal of Head and Face Pain, 2008, 48, 2
  75. 75
    B. Lee Peterlin, Anne H. Calhoun, Sherry Siegel, Ninan T. Mathew, Rational Combination Therapy in Refractory Migraine, Headache: The Journal of Head and Face Pain, 2008, 48, 6
  76. 76
    A. Straube, A. May, P. Kropp, Z. Katsarava, G. Haag, C. Lampl, P.S. Sándor, H.-C. Diener, S. Evers, Therapie primärer chronischer Kopfschmerzen, Der Schmerz, 2008, 22, 5, 531

    CrossRef

  77. 77
    Marco Aguggia, Treating headaches with botulinum toxin, Neurological Sciences, 2008, 29, S1, 137

    CrossRef

  78. 78
    Stefan Evers, Treatment of migraine with prophylactic drugs, Expert Opinion on Pharmacotherapy, 2008, 9, 15, 2565

    CrossRef

  79. 79
    John F. Rothrock, Treatment-Refractory Migraine: The Case for Opioid Therapy, Headache: The Journal of Head and Face Pain, 2008, 48, 6
  80. 80
    Glenn T. Clark, Alan Stiles, Larry Z. Lockerman, Sheldon G. Gross, A Critical Review of the Use of Botulinum Toxin in Orofacial Pain Disorders, Dental Clinics of North America, 2007, 51, 1, 245

    CrossRef

  81. 81
    Joel R. Saper, Ninan T. Mathew, Elizabeth W. Loder, Ronald DeGryse, Amanda M. VanDenburgh, A Double-Blind, Randomized, Placebo-Controlled Comparison of Botulinum Toxin Type A Injection Sites and Doses in the Prevention of Episodic Migraine, Pain Medicine, 2007, 8, 6
  82. 82
    M Relja, AC Poole, J Schoenen, J Pascual, X Lei, C Thompson, A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches, Cephalalgia, 2007, 27, 6
  83. 83
    Hsiu-Chih Liu, Botulinum Toxin Type A as a Prophylactic Treatment for Chronic Daily Headache: Time to Conduct a Large Clinical Trial in Taiwan?, Journal of the Chinese Medical Association, 2007, 70, 12, 519

    CrossRef

  84. 84
    Frederick G Freitag, Botulinum toxin type A in chronic migraine, Expert Review of Neurotherapeutics, 2007, 7, 5, 463

    CrossRef

  85. 85
    Valeria Tugnoli, Jay Guido Capone, Roberto Eleopra, Rocco Quatrale, Mariachiara Sensi, Ernesto Gastaldo, Maria Rosaria Tola, Pierangelo Geppetti, Botulinum Toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin, Pain, 2007, 130, 1, 76

    CrossRef

  86. 86
    Franci Stavropoulos, Barbara A. Hastie, Chronic Facial Pain in the Female Patient: Treatment Updates, Oral and Maxillofacial Surgery Clinics of North America, 2007, 19, 2, 245

    CrossRef

  87. You have free access to this content87
    Nabih M. Ramadan, Current Trends in Migraine Prophylaxis, Headache: The Journal of Head and Face Pain, 2007, 47,
  88. 88
    Peter J Goadsby, Emerging therapies for migraine, Nature Clinical Practice Neurology, 2007, 3, 11, 610

    CrossRef

  89. 89
    J.M. Láinez, J. Castillo, V.M. González, M. Otero, V. Mateos, R. Leira, J. Pascual, Guía de recomendaciones para el tratamiento de la migraña en la práctica clínica, Revista Clínica Española, 2007, 207, 4, 190

    CrossRef

  90. 90
    Mark Obermann, Zaza Katsarava, Management of medication-overuse headache, Expert Review of Neurotherapeutics, 2007, 7, 9, 1145

    CrossRef

  91. 91
    A. Panagariya, Pain Thresholds in Daily Transformed Migraine Versus Episodic Migraine Headache Patients, Yearbook of Neurology and Neurosurgery, 2007, 2007, 147

    CrossRef

  92. 92
    R. O. Millán-Guerrero, R. Isais-Millán, S. Barreto-Vizcaíno, L. Rivera-Castaño, A. Garcia-Solorzano, C. López-Blanca, M. Membrila-Maldonado, R. Muñoz-Solis, Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study, European Journal of Neurology, 2007, 14, 10
  93. 93
    Miguel J.A. Láinez, Anna Piera, Tinnitus: Pathophysiology and Treatment, 2007,

    CrossRef

  94. 94
    Stephen D. Silberstein, William B. Young, Textbook of Clinical Neurology, 2007,

    CrossRef

  95. 95
    S Evers, J Olesen, Botulinum toxin in headache treatment: the end of the road?, Cephalalgia, 2006, 26, 7
  96. 96
    Sheena Aurora, Botulinum toxin type A for the treatment of migraine, Expert Opinion on Pharmacotherapy, 2006, 7, 8, 1085

    CrossRef

  97. 97
    Daniel D. Truong, Wolfgang H. Jost, Botulinum toxin: Clinical use, Parkinsonism & Related Disorders, 2006, 12, 6, 331

    CrossRef

  98. 98
    Andrew D. Hershey, Marielle A. Kabbouche, Scott W. Powers, Chronic daily headaches in children, Current Pain and Headache Reports, 2006, 10, 5, 370

    CrossRef

  99. 99
    Hans-Christoph Diener, Kai Kronfeld, Gabriele Boewing, Margitta Lungenhausen, Christoph Maier, Albrecht Molsberger, Martin Tegenthoff, Hans-Joachim Trampisch, Michael Zenz, Rolf Meinert, Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial, The Lancet Neurology, 2006, 5, 4, 310

    CrossRef

  100. 100
    Moshe Jakubowski, Peter J. McAllister, Zahid H. Bajwa, Thomas N. Ward, Patty Smith, Rami Burstein, Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A, Pain, 2006, 125, 3, 286

    CrossRef

  101. 101
    Stefan Evers, Investigating prophylactic botulinum toxin type A for chronic headache disorders, Expert Opinion on Investigational Drugs, 2006, 15, 10, 1161

    CrossRef

  102. 102
    Peter J Goadsby, Migraine: emerging treatment options for preventive and acute attack therapy, Expert Opinion on Emerging Drugs, 2006, 11, 3, 419

    CrossRef

  103. 103
    Stephen D. Silberstein, Preventive treatment of migraine, Trends in Pharmacological Sciences, 2006, 27, 8, 410

    CrossRef

  104. 104
    Peter J. Goadsby, Squeezing life into botulinum toxin A in migraine: Imploding versus Exploding Pain, Pain, 2006, 125, 3, 206

    CrossRef

  105. 105
    Stefan Evers, Status on the use of botulinum toxin for headache disorders, Current Opinion in Internal Medicine, 2006, 5, 4, 336

    CrossRef

  106. 106
    Marcelo E. Bigal, Richard B. Lipton, The Preventive Treatment of Migraine, The Neurologist, 2006, 12, 4, 204

    CrossRef

  107. 107
    Ninan T. Mathew, The Prophylactic Treatment of Chronic Daily Headache, Headache: The Journal of Head and Face Pain, 2006, 46, 10
  108. 108
    Werner J. Becker, Suzanne N. Christie, Stephane Ledoux, Carin Binder, Topiramate Prophylaxis and Response to Triptan Treatment for Acute Migraine, Headache: The Journal of Head and Face Pain, 2006, 46, 9
  109. 109
    Mark A. Stacy, Handbook of Dystonia, 2006,

    CrossRef

  110. 110
    Martin A. Acquadro, Gary E. Borodic, Botulinum toxin efficacy for the treatment of pain, Journal of Clinical Anesthesia, 2005, 17, 5, 328

    CrossRef

  111. 111
    Stefan Evers, Achim Frese, Recent advances in the treatment of headaches, Current Opinion in Anaesthesiology, 2005, 18, 5, 563

    CrossRef

  112. 112
    S. Evers, J. Áfra, A. Frese, P. J. Goadsby, M. Linde, A. May, P. S. S´ndor, Drug Treatment of Migraine,
  113. 113
    Glenn T. Clark, Alan Stiles, Interventional Therapy and Injected Agents for Orofacial Pain and sPasm (Including Botulinum Toxin),
  114. 114
    Marcelo E. Bigal, Managing the Special Problem of Chronic Migraine,